Literature DB >> 26202698

Transperitoneal robotic resection of benign primary retroperitoneal tumors: can it be widely used?

Tian Zhang1, Xinjing Wang1, Liangchao Zhao1, Fei Liu1, Hao Chen1, Xiaxing Deng1, Chenghong Peng1, Baiyong Shen1.   

Abstract

BACKGROUND: This article was aimed to show the safety, flexibility and other advantages of transperitoneal robot-assisted resection of benign primary retroperitoneal tumors.
METHODS: Ten patients underwent robotic surgeries, and 31 underwent laparotomy surgeries from 2012 to 2014. The perioperative data, including tumor size, operation time, and other parameters were analyzed.
RESULTS: The tumor sizes of the two groups were not different (robotic group vs laparotomy group: 5.47 vs 5.32 cm, respectively; P = 0.777). The differences in the blood loss (robotic group vs laparotomy group: 80.00 vs. 146.08 mL, respectively; P = 0.021), time of oral intake (robotic group vs laparotomy group: 2.12 vs. 3.42 d, respectively; P = 0.045) and post-operation hospital stay (robotic group vs laparotomy group: 5.40 vs. 8.77 d, respectively; P = 0.004) were statistically significant and lower in the robotic group.
CONCLUSION: Robot-assisted resection of benign retroperitoneal tumors is flexible and safe and provides better protection when complex lesions are removed.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  da Vinci surgery system; minimally invasive technique; retroperitoneal neoplasm

Mesh:

Year:  2015        PMID: 26202698     DOI: 10.1002/rcs.1689

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  1 in total

1.  Robotic surgery in treatment of retroperitoneal tumors. Comparative single center study.

Authors:  S Berelavichus; A Kriger; A Kaldarov; V Panteleev; M Raevskaya
Journal:  J Robot Surg       Date:  2020-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.